Bayer Comes Under Fire for Claiming Their Vitamins Lower the Risk of Prostate Cancer

The Center for Science in the Public Interest (CSPI), a nutrition and food industry watchdog organization, has been openly critical as of late of an ad for Bayer's One-A-Day Men's Vitamins.

The point of contention comes when the vitamin commercial, regarding prostate cancer, states: "Now there's something that you can do that may help reduce your risk. Along with your regular doctor checkups, switch to One-A-Day Men's, a complete multivitamin plus selenium, which emerging research suggests may reduce the risk of prostate cancer."

The CSPI and other organizations are finding issue with this statement because of a large government-sponsored study involving 35,000 men which showed no decreased risk of prostate cancer in men taking selenium.

Photo by Stockbyte - Getty Images